Ansell Ltd
Company Profile
- Business description- Ansell is a leading supplier of protective gloves for use in healthcare and industrial settings, earning approximately 60% of revenue and 70% of operating profit from the healthcare segment and the remainder from the industrial segment. The company holds a large number of patents and the majority of sales come from its key branded product ranges. Ansell has a global manufacturing and distribution footprint and distributes via key partners as well as directly across more than 100 countries. In fiscal 2022, Ansell earned 45% of revenue in North America, 33% from Europe, Middle East and Africa, 14% across Asia-Pacific and the remaining 8% in Latin America. 
- Contact- 678 Victoria Street 
 Level 3
 Richmond
 MelbourneVIC3121
 AUS- T: +61 392707222 
- Sector- Healthcare - Stock type- Defensive 
- Industry- Medical Instruments & Supplies - Fiscal Year End- 30 June 2026 - Employees- 15,724 
Ansell Ltd News & Analysis
stocks
ASX results reaction: WiseTech, Woolies, Sigma and more
stocks
ASX healthcare stocks shrug off new tariff threat
stocks
3 cheap ASX shares with sound balance sheets
Morningstar Investment Ideas
Markets
| Index | Last price | Change | % Change | 
|---|---|---|---|
| All Ordinaries | 9,178.00 | 28.70 | -0.31% | 
| CAC 40 | 8,128.22 | 29.07 | -0.36% | 
| DAX 40 | 24,003.80 | 115.09 | -0.48% | 
| Dow JONES (US) | 47,522.12 | 109.88 | -0.23% | 
| FTSE 100 | 9,717.59 | 42.47 | -0.44% | 
| HKSE | 25,906.65 | 376.04 | -1.43% | 
| NASDAQ | 23,581.14 | 377.33 | -1.57% | 
| Nikkei 225 | 52,411.34 | 1,085.73 | 2.12% | 
| NZX 50 Index | 13,548.32 | 89.03 | 0.66% | 
| S&P 500 | 6,822.34 | 68.25 | -0.99% | 
| S&P/ASX 200 | 8,881.90 | 31.30 | -0.35% | 
| SSE Composite Index | 3,954.79 | 32.11 | -0.81% |